Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartwig Huland

Showing results (51-60 of 368) with videos related to

Pageof 37
Sort By:
JAMA Network Open|April 3, 2020
Association of Age With Risk of Adverse Pathological Findings at Radical Prostatectomy in Men With Gleason Score 6 Prostate CancerDaniel W Kim, Ming-Hui Chen, Hartwig Huland, et al.
The Journal of Urology|July 20, 2002
Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 testsMartin G Friedrich, Angelika Hellstern, Stefan H Hautmann, et al.
European Journal of Radiology|September 24, 2019
Predictors of short and long term urinary incontinence after radical prostatectomy in prostate MRI: Significance and reliability of standardized measurementsMarkus Sauer, Pierre Tennstedt, Christoph Berliner, et al.
The Journal of Urology|January 17, 2002
Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinomaStefan Conrad, Markus Graefen, Uwe Pichlmeier, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 1, 2008
Prevalence of human gammaretrovirus XMRV in sporadic prostate cancerNicole Fischer, Olaf Hellwinkel, Claudia Schulz, et al.
BJU International|January 20, 2012
Advances in the management of high-risk localised and metastatic prostate cancerJoaquim Bellmunt, Gerhardt Attard, Amit Bahl, et al.
The Journal of Urology|October 24, 2002
Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigenThomas Steuber, Paulina Nurmikko, Alexander Haese, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2005
Surgical management of prostate cancer: advances based on a rational approach to the dataAnoop M Meraney, Alexander Haese, Jüri Palisaar, et al.
Advances in Experimental Medicine and Biology|August 24, 2007
Inhibition of dendritic cell generation and function by serum from prostate cancer patients: correlation with serum-free PSAMaryam Aalamian-Matheis, Gurkamal S Chatta, Michael R Shurin, et al.
European Urology|July 4, 2008
Editorial comment on: Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsySascha A Ahyai, Christian Eichelberg, Hendrik Isbarn, et al.
Pageof 37

Showing results (51-60 of 368) with videos related to

Sort By:
Pageof 37
JAMA Network Open|April 3, 2020
Association of Age With Risk of Adverse Pathological Findings at Radical Prostatectomy in Men With Gleason Score 6 Prostate CancerDaniel W Kim, Ming-Hui Chen, Hartwig Huland, et al.
The Journal of Urology|July 20, 2002
Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 testsMartin G Friedrich, Angelika Hellstern, Stefan H Hautmann, et al.
European Journal of Radiology|September 24, 2019
Predictors of short and long term urinary incontinence after radical prostatectomy in prostate MRI: Significance and reliability of standardized measurementsMarkus Sauer, Pierre Tennstedt, Christoph Berliner, et al.
The Journal of Urology|January 17, 2002
Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinomaStefan Conrad, Markus Graefen, Uwe Pichlmeier, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 1, 2008
Prevalence of human gammaretrovirus XMRV in sporadic prostate cancerNicole Fischer, Olaf Hellwinkel, Claudia Schulz, et al.
BJU International|January 20, 2012
Advances in the management of high-risk localised and metastatic prostate cancerJoaquim Bellmunt, Gerhardt Attard, Amit Bahl, et al.
The Journal of Urology|October 24, 2002
Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigenThomas Steuber, Paulina Nurmikko, Alexander Haese, et al.
European Journal of Cancer (Oxford, England : 1990)|April 6, 2005
Surgical management of prostate cancer: advances based on a rational approach to the dataAnoop M Meraney, Alexander Haese, Jüri Palisaar, et al.
Advances in Experimental Medicine and Biology|August 24, 2007
Inhibition of dendritic cell generation and function by serum from prostate cancer patients: correlation with serum-free PSAMaryam Aalamian-Matheis, Gurkamal S Chatta, Michael R Shurin, et al.
European Urology|July 4, 2008
Editorial comment on: Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsySascha A Ahyai, Christian Eichelberg, Hendrik Isbarn, et al.
Pageof 37